Arimidex in McCune Albright Syndrome

Bioequivalence Study Comparing Arimidex Tablet and Anastrozole ODF in Japanese Healthy Male Subjects

NCT01568281 ·Status: COMPLETED ·Phase: PHASE1

Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer

NCT00638391 ·Status: COMPLETED

Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer

NCT00562458 ·Status: COMPLETED

Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer

NCT01138553 ·Status: TERMINATED ·Phase: EARLY_PHASE1

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

NCT01381874 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction

NCT00213148 ·Status: COMPLETED ·Phase: PHASE2

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

NCT07287098 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer

NCT00303615 ·Status: TERMINATED ·Phase: PHASE2

Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex

NCT00235937 ·Status: COMPLETED ·Phase: PHASE2

Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer

NCT00078832 ·Status: COMPLETED ·Phase: PHASE3

Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer

NCT00253539 ·Status: COMPLETED ·Phase: PHASE2

Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients

NCT00128843 ·Status: COMPLETED ·Phase: PHASE2

Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer

NCT00088010 ·Status: COMPLETED ·Phase: PHASE3

Secondary Adjuvant Long Term Study With Arimidex

NCT00295620 ·Status: COMPLETED ·Phase: PHASE3

Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve

NCT02113553 ·Status: TERMINATED ·Phase: PHASE2

Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.

NCT00287534 ·Status: COMPLETED ·Phase: PHASE2

Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer

NCT00588003 ·Status: COMPLETED ·Phase: PHASE1

Prospective Study of UDP-gluconoryltransferase 2B17 Genotype as a Predictive Marker of Exemestane PK and PD

NCT01655004 ·Status: UNKNOWN ·Phase: NA

Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?

NCT00766532 ·Status: COMPLETED ·Phase: PHASE4

Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer

NCT00083174 ·Status: COMPLETED ·Phase: PHASE3

Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease

NCT00200174 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer

NCT02007512 ·Status: COMPLETED ·Phase: PHASE2

Liver Safety Under Upfront Arimidex vs Tamoxifen

NCT00537771 ·Status: COMPLETED ·Phase: PHASE4

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy

NCT00556374 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP）

NCT03137368 ·Status: UNKNOWN ·Phase: PHASE3